Placenta Accreta Spectrum
- PMID: 37290094
- PMCID: PMC10491415
- DOI: 10.1097/AOG.0000000000005229
Placenta Accreta Spectrum
Abstract
Placenta accreta spectrum (PAS) is one of the most dangerous conditions in pregnancy and is increasing in frequency. The risk of life-threatening bleeding is present throughout pregnancy but is particularly high at the time of delivery. Although the exact cause is unknown, the result is clear: Severe PAS distorts the uterus and surrounding anatomy and transforms the pelvis into an extremely high-flow vascular state. Screening for risk factors and assessing placental location by antenatal ultrasonography are essential for timely diagnosis. Further evaluation and confirmation of PAS are best performed in referral centers with expertise in antenatal imaging and surgical management of PAS. In the United States, cesarean hysterectomy with the placenta left in situ after delivery of the fetus is the most common treatment for PAS, but even in experienced referral centers, this treatment is often morbid, resulting in prolonged surgery, intraoperative injury to the urinary tract, blood transfusion, and admission to the intensive care unit. Postsurgical complications include high rates of posttraumatic stress disorder, pelvic pain, decreased quality of life, and depression. Team-based, patient-centered, evidence-based care from diagnosis to full recovery is needed to optimally manage this potentially deadly disorder. In a field that has relied mainly on expert opinion, more research is needed to explore alternative treatments and adjunctive surgical approaches to reduce blood loss and postoperative complications.
Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Financial Disclosure Lisa C. Zuckerwise reports money was paid to her institution from Laborie Medical Technologies Corp for an ongoing clinical study unrelated to placenta accreta spectrum. She received payment from Gershon, Willoughby & Getz, LLC, and Huff, Powell & Bailey, LLC for legal expert consulting not related to placenta accreta spectrum. The other authors did not report any potential conflicts of interest.
Figures



Similar articles
-
Quantifying placenta accreta spectrum severity and its associated blood loss: a novel transvaginal ultrasound scoring system.Am J Obstet Gynecol MFM. 2024 Oct;6(10):101451. doi: 10.1016/j.ajogmf.2024.101451. Epub 2024 Aug 5. Am J Obstet Gynecol MFM. 2024. PMID: 39096965
-
Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2024 Oct;6(10):101432. doi: 10.1016/j.ajogmf.2024.101432. Epub 2024 Jul 26. Am J Obstet Gynecol MFM. 2024. PMID: 39069207
-
Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.Ultrasound Obstet Gynecol. 2022 Sep;60(3):381-389. doi: 10.1002/uog.24889. Ultrasound Obstet Gynecol. 2022. PMID: 35247287 Free PMC article.
-
Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study.Acta Obstet Gynecol Scand. 2021 Mar;100 Suppl 1:41-49. doi: 10.1111/aogs.14120. Epub 2021 Mar 12. Acta Obstet Gynecol Scand. 2021. PMID: 33713033
-
Placenta Accreta Spectrum: Prenatal Diagnosis and Management.Obstet Gynecol Clin North Am. 2022 Sep;49(3):423-438. doi: 10.1016/j.ogc.2022.02.004. Obstet Gynecol Clin North Am. 2022. PMID: 36122977 Review.
Cited by
-
Association between congenital uterine anomalies and placenta accreta spectrum.F S Rep. 2025 Jan 16;6(1):67-72. doi: 10.1016/j.xfre.2025.01.006. eCollection 2025 Mar. F S Rep. 2025. PMID: 40201106 Free PMC article.
-
Predicting placenta accreta spectrum and high postpartum hemorrhage risk using radiomics from T2-weighted MRI.BMC Pregnancy Childbirth. 2025 Apr 4;25(1):398. doi: 10.1186/s12884-025-07516-0. BMC Pregnancy Childbirth. 2025. PMID: 40186143 Free PMC article.
-
Validity of ICD-10 diagnosis codes for placenta accreta spectrum disorders.Paediatr Perinat Epidemiol. 2024 Jul;38(5):435-439. doi: 10.1111/ppe.13076. Epub 2024 Mar 21. Paediatr Perinat Epidemiol. 2024. PMID: 38514907 Free PMC article.
-
Predicting the risk of cesarean hysterectomy in the management of placenta accreta spectrum disorders: a new model based on clinical findings and ultrasonography.Arch Gynecol Obstet. 2025 Jan;311(1):55-66. doi: 10.1007/s00404-024-07858-8. Epub 2024 Dec 12. Arch Gynecol Obstet. 2025. PMID: 39668205
-
Association of Paternal Age Alone and Combined with Maternal Age with Perinatal Outcomes: A Prospective Multicenter Cohort Study in China.J Epidemiol Glob Health. 2024 Mar;14(1):120-130. doi: 10.1007/s44197-023-00175-4. Epub 2024 Jan 8. J Epidemiol Glob Health. 2024. PMID: 38190051 Free PMC article.
References
-
- Morlando M, Schwickert A, Stefanovic V, et al. Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study. Acta Obstet Gynecol Scand 2021;100 Suppl 1:41–49. doi: 10.1111/aogs.14120 [published Online First: 2021/March/14] - DOI - PubMed
-
- Placenta accreta spectrum. Obstetric Care Consensus No. 7. American College of Obstetricians and Gynecologists. Obstetrics and Gynecology 2018;132:e259–75. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources